Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway

BACKGROUND: The present study aimed to evaluate the suppressive role of interleukin (IL)-25 in IL-22-induced osteoclastogenesis and receptor activator of nuclear factor κB ligand (RANKL) expression in rheumatoid arthritis (RA). METHODS: Serum from patients with RA and osteoarthritis (OA), and health...

詳細記述

保存先:
書誌詳細
出版年:Arthritis Res Ther
主要な著者: Min, Hong Ki, Won, Ji-Yeon, Kim, Bo-Mi, Lee, Kyung-Ann, Lee, Seoung-Joon, Lee, Sang-Heon, Kim, Hae-Rim, Kim, Kyoung-Woon
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7517649/
https://ncbi.nlm.nih.gov/pubmed/32972460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02315-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料